Similar breast cancer cell contamination of single-day peripheral-blood progenitor-cell collections obtained after priming with hematopoietic growth factor alone or after cyclophosphamide followed by growth factor

Journal of Clinical Oncology

Volumn 14, Issue 9, 1996, Pages 2569-2575

  Passos Coelho, J L ^a   Ross, A A ^a   Kahn, D J ^a   Moss, T J ^a   Davis, J M ^a   Huelskamp, A M ^a   Noga, S J ^a   Davidson, N E ^a   Kennedy, M J ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ADULT; ADVANCED CANCER; ARTICLE; BREAST CANCER; CANCER STAGING; CLINICAL ARTICLE; CLINICAL TRIAL; CLONOGENESIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; METASTASIS POTENTIAL; PRIORITY JOURNAL;

EID: 0029782632     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1996.14.9.2569     Document Type: Article

References (30)

1. Vahdat L, Antman KH: Dose-intensive therapy in breast cancer, in Armitage JO, Antman KH (eds): High-Dose Cancer Therapy (ed 2). Baltimore, MD, Williams & Wilkins, 1995, pp 802-823
2. Peters WP: Autologous bone marrow transplantation for breast cancer, in Forman SJ, Blume KG, Thomas ED (eds): Bone Marrow Transplantation (ed 1). Boston, MA, Blackwell Scientific, 1994, pp 789-801
3. Bezwoda WR, Seymour L, Dansey RD: High-dose chemotherapy with hematopoietic rescue as primary treatment for metastatic breast cancer: A randomized trial. J Clin Oncol 13:2483-2489, 1995
4. Peters WP, Ross M, Vredenburgh JJ, et al: High-dose chemotherapy and autologous bone marrow support as consolidation after standard-dose adjuvant therapy for high-risk primary breast cancer. J Clin Oncol 11:1132-1143, 1993
5. Gianni AM, Siena S, Bregni M, et al: Five-year results of high-dose sequential (HDS) adjuvant chemotherapy in breast cancer with ≥ 10 positive nodes. Proc Am Soc Clin Oncol 14:90, 1995 (abstr 61)
6. Vaughan WP, Mann SL, Garvey J, et al: Breast cancer detected in cell culture of histologically negative bone marrow predicts systemic relapse in patients with stage I, II, III and locally recurrent disease. Proc Am Soc Clin Oncol 9:9, 1990 (abstr 27)
7. Sharp JG, Kessinger A, Vaughan WP, et al: Detection and clinical significance of minimal tumor contamination of peripheral blood stem cell harvests. Int J Cell Cloning 10:92-94, 1992 (suppl 1)
8. Brenner M, Rill D, Moen R, et al: Gene-marking to trace origin of relapse after autologous bone-marrow transplantation. Lancet 341:85-86, 1993
9. Rill DR, Santana VM, Roberts WM, et al: Direct demonstration that autologous bone marrow transplantation for solid tumors can return a multiplicity of tumorigenic cells. Blood 84:380-383, 1994
10. Kessinger A, Armitage JO: The use of peripheral stem cell support of high-dose chemotherapy, in DeVita VT, Hellman S, Rosenberg SA (eds): Important Advances in Oncology. Philadelphia, PA, Lippincott, 1993, pp 167-175
11. Gianni A, Siena S, Bregni M, et al: Granulocyte-macrophage colony-stimulating factor to harvest circulating hematopoietic stem cells for autotransplantation. Lancet 2:580-585, 1989
12. Sheridan WP, Begley CG, Juttner CA, et al: Effect of peripheral-blood progenitor cells mobilized by G-CSF on platelet recovery after high-dose chemotherapy. Lancet 339:640-644, 1992
13. To LB, Roberts MM, Haylock DN, et al: Comparison of hematological recovery times and supportive care requirements of autulogous recovery phase peripheral blood stem cell transplants, autologous bone marrow transplants and allogeneic bone marrow transplants. Bone Marrow Transplant 9:277-284, 1992
14. Shpall EJ, Jones RB, Bearman SI, et al: Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: Influence of CD34-positive peripheral blood progenitors and growth factors on engraftment. J Clin Oncol 12:28-36, 1994
15. Passos-Coelho JL, Braine HG, Davis JM, et al: Predictive factors for peripheral blood progenitor cell collections using a single large volume leukapheresis after cyclophosphamide and granulocyte-macrophage colony stimulating factor mobilization. J Clin Oncol 13:705-714, 1995
16. Ross AA, Cooper BW, Lazarus HM, et al: Detection and viability of tumor cells in peripheral blood stem cell collections from breast cancer patients using immunocytochemical and clonogenic assay techniques. Blood 82:2605-2610, 1993
17. Douer D, Chaiwun B, Glaspy J, et al: Analysis of peripheral blood progenitor cell harvests for tumor contamination using a sensitive immunohistochemical method. Proc Am Soc Clin Oncol 12:51, 1993 (abstr)
18. Datta YH, Adams PT, Drobyski WR, et al: Sensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction. J Clin Oncol 12:475-482, 1994
19. Passos-Coelho J, Ross AA, Davis JA, et al: Bone marrow micrometastases in chemotherapy-responsive advanced breast cancer: Effect of ex-vivo purging with 4-hydroperoxycyclophosphamide. Cancer Res 54:2366-2371, 1994
20. Brugger W, Bross KJ, Glatt M, et al: Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors. Blood 83:636-640, 1994
21. Passos-Coelho JL, Ross AA, Moss TJ, et al: Absence of breast cancer cell mobilization into peripheral blood progenitor cell collections by priming with cyclophosphamide and granulocytemacrophage colony-stimulating factor. Blood 85:1138-1143, 1995
22. Kennedy MJ, Hess AD, Passos-Coelho JL, et al: Peripheral blood progenitor cell infusions do not inhibit the induction of graft-versus-host disease by cyclosporine A following high-dose chemotherapy. Proc Am Soc Clin Oncol 14:312, 1995 (abstr 915)
23. Kennedy MJ, Vogelsang GB, Jones RJ, et al: Phase I trial of interferon-gamma to potentiate cyclosporine A-induced graft-versus-host-disease in women undergoing autologous bone marrow transplantation for breast cancer. J Clin Oncol 12:249-257, 1994
24. Passos-Coelho JL, Braine HG, Wright SK, et al: Large volume leukapheresis using regional citrate anticoagulation to collect peripheral blood progenitor cells. J Hematother 4:11-19, 1995
25. Kennedy MJ, Armstrong DK, Huelskamp AM, et al: Phase I and pharmacologic study of the alkylating agent modulator novobiocin in combination with high-dose chemotherapy for the treatment of metastatic breast cancer. J Clin Oncol 13:1136-1143, 1995
26. Ross AA, Moss TJ, Weintraub C, et al: In-vitro clonogenic growth of bone marrow micrometastases from patients with breast cancer. Breast Cancer Res Treat 27:169, 1993 (abstr 169)
27. Ross AA, Cooper BW, Lazarus HM, et al: Incidence of tumor cell contamination in peripheral blood stem cell collections from breast cancer patients. Proc Am Soc Clin Oncol 12:69, 1993 (abstr 77)
28. Rowley SD, Zuehlsdorf M, Braine HG, et al: CFU-GM content of bone marrow graft correlates with time to hematologic reconstitution following autologous bone marrow transplantation with 4-hydroperoxycyclophosphamide-purged bone marrow. Blood 70:271-275, 1987
29. Trischman TM, Schepers KG, Civin C: Measurement of CD34+ cells in bone marrow by flow cytometry. J Hematother 2:305-313, 1993
30. Pantel K, Schlimok G, Ansstwurm M, et al: Methodological analysis of immunocytochemical screening for disseminated epithelial tumor cells in bone marrow. J Hematother 3:165-173, 1994